// App-Quantinova.ai

515 : Clinical Responses in Patients with Inadequate Response to bDMARDs upon Treatment with Upadacitinib

Researchers

Presenter

  • Glen Thomson

Principal Investigators

  • Kun Chen

  • Sebastian Meerwein

  • Casey Schlacher

  • John Cush

Medical Centers

  • Brigham and Women's Hospital, Boston, MA, USA, Boston, MA

  • CIADS Research, Winnipeg, Canada

  • AbbVie, Inc., North Chicago, IL

  • AbbVie GmbH Co. KG, Ludwigshafen, Germany, Wiesbaden, Germany

  • AbbVie, Inc., North Chicago, IL

  • Baylor University Medical Center, Dallas, TX

Locations

  • United States

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Plasminogen Activator, Urokinase

Drug/Treatment

  • ABT-494

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved